The number of women who've quietly admitted they handed in their notice during the worst of their perimenopause symptoms — and wished they'd waited six months — is striking. It doesn't mean the decision was always wrong. But it does mean the timing was doing some of the deciding for them, and that's worth knowing before you sign anything.
Learn more about Rose →Declining estrogen directly affects the brain's prefrontal cortex, the region responsible for working memory, executive function, and sustained concentration. During perimenopause, this can translate into a genuine inability to perform tasks that once felt routine — drafting reports, managing spreadsheets, holding strategic conversations. This is a documented neurological effect of hormonal fluctuation, not a permanent cognitive decline, and it often improves significantly once hormone levels stabilize, either naturally or with treatment.
Night sweats — driven by fluctuating estrogen and its effect on the hypothalamic thermostat — can fragment sleep so severely that women accumulate weeks of sleep debt over months. Chronic sleep deprivation produces symptoms almost identical to occupational burnout: emotional exhaustion, disengagement, impaired judgment, and a feeling that nothing is worth the effort. A woman evaluating her career during this period is effectively doing so while cognitively impaired, which is a fact worth sitting with before making irreversible decisions.
Progesterone has a calming, GABA-modulatory effect on the nervous system, and as it drops in perimenopause, many women experience new or worsening anxiety with no obvious external cause. When that anxiety lives in the body during work hours, it is easily and understandably attributed to the job itself — the meetings, the deadlines, the commute. Separating hormonally generated anxiety from a genuinely toxic work environment requires deliberate investigation, ideally with clinical support, before a career decision is made.
Estrogen modulates serotonin and dopamine pathways, and its erratic decline during perimenopause can produce mood swings, irritability, and a lowered threshold for frustration that feels entirely out of character. A difficult manager, a tense team dynamic, or a single bad performance review can feel catastrophically personal during this phase in ways it simply wouldn't have five years earlier. Women who have exited jobs citing relationship breakdowns have later recognized that their hormonal state was amplifying conflict rather than creating it.
Perimenopausal fatigue is physiologically distinct from ordinary tiredness — it involves mitochondrial disruption, disrupted cortisol rhythms, and the cumulative toll of poor sleep, all of which conspire to make previously energizing work feel hollow and draining. This kind of fatigue can recolor an entire professional identity, leading a woman to conclude she has lost her passion when the more accurate story is that her body is currently unable to generate the neurochemistry that makes passion feel accessible. Treating the underlying hormonal disruption often restores a sense of engagement that seemed permanently gone.
A hallmark of severe perimenopause is an overwhelming desire to escape — noise, obligation, complexity, people — which clinically overlaps with the withdrawal and anhedonia seen in depression. This sensation can attach itself to a career and present as a clear, urgent signal to quit, when it is actually the nervous system's cry for relief from hormonal dysregulation. Recognizing this as a symptom rather than a strategic insight is not about dismissing a woman's intelligence; it is about ensuring that a permanent decision isn't made to solve a temporary biological state.
Perimenopause coincides with a well-documented psychological period of identity re-evaluation, sometimes described in the literature as a midlife transition, where women genuinely reassess values, roles, and what constitutes a meaningful life. This is a legitimate and important process — but it unfolds in parallel with hormonal chaos that distorts emotional perception. A career exit made at the peak of this instability may reflect real values, or it may reflect the despair of a bad hormonal month, and the two are genuinely difficult to distinguish without giving the transition time to settle.
Menopausal hormone therapy, when appropriate and initiated during the perimenopause window, has robust evidence for improving sleep quality, reducing cognitive fog, stabilizing mood, and alleviating fatigue — the precise cluster of symptoms most likely to drive a premature career exit. Women who try HRT before making a retirement decision sometimes report feeling like a different person within weeks, which reframes the entire question of whether leaving was ever necessary. This is not an argument for or against any treatment, but a data point that deserves to be part of the decision-making process.
Financial planners and career counselors who work with women in midlife have increasingly noted a pattern of exits made during acute perimenopausal episodes that are later regretted, particularly by women who exit before pension thresholds, vesting dates, or Medicare eligibility. A practical, evidence-informed approach is treating any major exit decision made during active, untreated perimenopause symptoms as a draft rather than a final answer — revisiting it after at least 90 days of consistent symptom management. This preserves optionality without requiring a woman to stay somewhere genuinely harmful, and it acknowledges that both the hormones and the feelings are real.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.